12 results
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
to provide “no fault” compensation to any study subject injured in the clinical trial.
During the development of a medicinal product, the EMA
6-K
EX-1
AUTL
Autolus Therapeutics plc
30 Jun 21
Annual Report and Accounts
6:05am
, and in most European Union countries, the sponsor is liable to provide “no fault” compensation to any study subject injured in the clinical trial
6-K
EX-1
AUTL
Autolus Therapeutics plc
26 May 20
Current report (foreign)
4:31pm
subject injured in the clinical trial.
Prior to commencing a clinical trial, the sponsor must obtain a clinical trial authorization from the competent
20-F
1zx1slhik9k ua0
23 Nov 18
Annual report (foreign)
12:00am
424B4
d8v7 jjujkk7tx
22 Jun 18
Prospectus supplement with pricing info
4:02pm
F-1/A
0qneuq
19 Jun 18
Registration statement (foreign) (amended)
8:05am
F-1/A
3eejjl6r lc
8 Jun 18
Registration statement (foreign) (amended)
6:25am
F-1/A
ukfrcxc
10 May 18
Registration statement (foreign) (amended)
5:19pm
F-1
b6w4usr0jg7m4gouzw
7 May 18
Registration statement (foreign)
4:45pm
- Prev
- 1
- Next